Nandabalan Krishnan
Insider CIK 1733387 · BTAI Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2023-04-06 | 2023-04-10 | 60,000 | — | $0 | 294,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2023-04-06 | 2023-04-10 | 60,000 | $17.32 | $1.04M | 0 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2023-04-06 | 2023-04-10 | 60,000 | $0.41 | $24.6K | 60,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2023-01-05 | 2023-01-06 | 25,889 | — | $0 | 354,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2023-01-05 | 2023-01-06 | 25,889 | $0.41 | $10.6K | 25,889 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2023-01-05 | 2023-01-06 | 25,089 | $22.32 | $560.0K | 800 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2023-01-05 | 2023-01-06 | 800 | $22.93 | $18.3K | 0 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2023-01-04 | 2023-01-06 | 34,111 | — | $0 | 379,889 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2023-01-04 | 2023-01-06 | 9,821 | $22.21 | $218.1K | 0 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2023-01-04 | 2023-01-06 | 34,111 | $0.41 | $14.0K | 34,111 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2023-01-04 | 2023-01-06 | 24,290 | $21.59 | $524.4K | 9,821 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2022-11-11 | 2022-11-14 | 32,550 | — | $0 | 414,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2022-11-11 | 2022-11-14 | 32,550 | $15.00 | $488.3K | 0 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2022-11-11 | 2022-11-14 | 32,550 | $0.41 | $13.3K | 32,550 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2022-11-10 | 2022-11-14 | 27,450 | — | $0 | 446,550 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2022-11-10 | 2022-11-14 | 27,450 | $15.00 | $411.8K | 0 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2022-11-10 | 2022-11-14 | 27,450 | $0.41 | $11.3K | 27,450 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2021-06-25 | 2021-06-29 | 473,250 | $30.83 | $14.59M | 8,546,750 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | J Other | 2020-07-24 | 2021-02-16 | 80,000 | $60.76 | $4.86M | 80,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | J Other | 2020-07-24 | 2021-02-16 | 160,000 | $60.76 | $9.72M | 9,020,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | D To issuer | 2020-02-24 | 2020-05-13 | 300,000 | $30.08 | $9.02M | 9,180,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2020-01-02 | 2020-04-28 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | G Gift | 2019-04-01 | 2021-02-16 | 1,000 | — | $0 | 0 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | G Gift | 2019-04-01 | 2021-02-16 | 1,000 | — | $0 | 1,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | P Buy | 2018-11-29 | 2018-11-30 | 1,000 | $4.92 | $4.9K | 1,000 | SEC↗ |